Physician profile
Thomas Wong
NPI 1528555869
$5,824.03
in general payments reported to CMS, 2019-2025
7 companies · $2,217 in 2025
The $2,217 reported for 2025 was more than what 76% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $3,607 · 2025: $2,217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,361 · Travel and Lodging: $2,463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,361.11 |
| Travel and Lodging | $2,462.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,497.88 | 2024-2025 | Ruby Coil, Indigo System |
| Boston Scientific Corporation | $1,465.59 | 2024-2025 | Obsidio, General - Embolics, Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) |
| Stryker Corporation | $447.85 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Clottriever Bold Catheter |
| Sirtex Medical INC | $168.35 | 2025 | Sir-Spheres Microspheres |
| Terumo Medical Corporation | $141.35 | 2024-2025 | Azur Cx Detachable |
| Medtronic, INC. | $94.24 | 2025 | Mvp, Protege Rx |
| Inari Medical, INC. | $8.77 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.